Novel approaches in molecular imaging and targeted therapeutics are transforming the management of renal cell carcinoma (RCC) and urothelial carcinoma (UC). This review focuses on three key areas of ...
The management of renal cell carcinoma (RCC) has transformed over the past 20 years, and recent advances in diagnostic and therapeutic modalities have the potential to further improve patient outcomes ...
Renal cell carcinoma is the most common form of kidney cancer. It can take time to fully process a diagnosis and what, ...
Understanding the specific tumor characteristics associated with detectable circulating tumor DNA (ctDNA) in patients with renal cell carcinoma (RCC) is critical for informing future studies aiming to ...
Dr. Joshua Sabai spoke with Dr. Chandler Park about the latest advances in kidney cancer, highlighting clinical trials that are shaping care for patients.
Stage 2 kidney cancer involves a tumor over 7 cm, confined to the kidney, often treated surgically. Diagnosis includes imaging, blood tests, and possibly biopsy to confirm cancer type and stage.
A specialist in treating kidney cancer patients explained why the rare cancer struck someone at such a young age.
Elevated calcium levels in the blood—a complication of kidney cancers known as hypercalcemia—may be successfully treated with a class of medications called HIF-2α inhibitors developed by UT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback